Lakeside Holding Ltd (LSH) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-Q, Lakeside Holding Ltd's filing signal continuing negative.

Lakeside Holding Limited is a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market, particularly China and South Korea. The company offers customized ocean freight and airfreight solutions in the U.S. for transporting goods into the U.S., encompassing freight consolidation, customs clearance, warehousing, distribution, and U.S. domestic ground transportation. In 2025, Lakeside expanded into pharmaceutical distribution through its acquisition of Hupan Pharmaceutical in China, which distributes infusion fluids. Its customer base consists of Asia- and U.S.-based logistics companies serving e-commerce platforms, social commerce platforms, and manufacturers. Lakeside operates three regional warehousing and distribution centers in Illinois and Texas, leveraging a network of over 150 warehouses and distribution terminals across the U.S.

Revenue is primarily generated from providing customized cross-border ocean and air freight solutions, including consolidation, customs clearance, warehousing, distribution, and U.S. domestic ground transportation. A secondary revenue stream comes from the distribution of pharmaceutical and medical products in China.